1-154587122-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001111.5(ADAR):​c.3020-759A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.385 in 151,928 control chromosomes in the GnomAD database, including 12,664 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as protective (no stars).

Frequency

Genomes: 𝑓 0.38 ( 12664 hom., cov: 32)

Consequence

ADAR
NM_001111.5 intron

Scores

2

Clinical Significance

protective no assertion criteria provided B:1

Conservation

PhyloP100: -0.162

Publications

10 publications found
Variant links:
Genes affected
ADAR (HGNC:225): (adenosine deaminase RNA specific) This gene encodes the enzyme responsible for RNA editing by site-specific deamination of adenosines. This enzyme destabilizes double-stranded RNA through conversion of adenosine to inosine. Mutations in this gene have been associated with dyschromatosis symmetrica hereditaria. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2010]
ADAR Gene-Disease associations (from GenCC):
  • Aicardi-Goutieres syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • dyschromatosis symmetrica hereditaria
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • Aicardi-Goutieres syndrome 6
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • familial infantile bilateral striatal necrosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Leigh syndrome
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.591 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADARNM_001111.5 linkc.3020-759A>G intron_variant Intron 11 of 14 ENST00000368474.9 NP_001102.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADARENST00000368474.9 linkc.3020-759A>G intron_variant Intron 11 of 14 1 NM_001111.5 ENSP00000357459.4

Frequencies

GnomAD3 genomes
AF:
0.385
AC:
58391
AN:
151810
Hom.:
12636
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.597
Gnomad AMI
AF:
0.338
Gnomad AMR
AF:
0.276
Gnomad ASJ
AF:
0.270
Gnomad EAS
AF:
0.310
Gnomad SAS
AF:
0.236
Gnomad FIN
AF:
0.349
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.309
Gnomad OTH
AF:
0.360
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.385
AC:
58464
AN:
151928
Hom.:
12664
Cov.:
32
AF XY:
0.381
AC XY:
28259
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.597
AC:
24732
AN:
41418
American (AMR)
AF:
0.276
AC:
4210
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.270
AC:
937
AN:
3470
East Asian (EAS)
AF:
0.310
AC:
1602
AN:
5174
South Asian (SAS)
AF:
0.234
AC:
1125
AN:
4806
European-Finnish (FIN)
AF:
0.349
AC:
3678
AN:
10550
Middle Eastern (MID)
AF:
0.310
AC:
91
AN:
294
European-Non Finnish (NFE)
AF:
0.309
AC:
21010
AN:
67926
Other (OTH)
AF:
0.365
AC:
771
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1699
3399
5098
6798
8497
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
528
1056
1584
2112
2640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.346
Hom.:
4543
Bravo
AF:
0.389
Asia WGS
AF:
0.309
AC:
1074
AN:
3478

ClinVar

Significance: protective
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Colorectal cancer Benign:1
Mar 01, 2022
Colorectal Cancer Research Lab, Singapore General Hospital
Significance:protective
Review Status:no assertion criteria provided
Collection Method:case-control

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.4
DANN
Benign
0.66
PhyloP100
-0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2131902; hg19: chr1-154559598; API